Barclays PLC Boston Scientific Corp Call Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	SELL	$72.96 - $84.0 $58.5 Million - $67.4 Million	-802,400 Reduced 81.79%	178,700 $15 Million
Q2 2024 Aug 14, 2024	BUY	$67.33 - $77.71 $66.1 Million - $76.2 Million	981,100 New	981,100 $75.6 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $4.43 Million - $4.88 Million	108,300 Added 112.93%	204,200 $9.04 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $3.26 Million - $3.84 Million	85,600 Added 831.07%	95,900 $4.07 Million
Q2 2020 Aug 12, 2020	SELL	$30.19 - $39.11 $3.35 Million - $4.35 Million	-111,100 Reduced 91.52%	10,300 $362,000
Q1 2020 May 13, 2020	BUY	$25.83 - $45.71 $1.31 Million - $2.33 Million	50,900 Added 72.2%	121,400 $3.96 Million
Q4 2019 Feb 10, 2020	BUY	$37.87 - $45.37 $337,043 - $403,793	8,900 Added 14.45%	70,500 $3.19 Million
Q3 2019 Nov 14, 2019	SELL	$40.31 - $43.45 $2.64 Million - $2.85 Million	-65,600 Reduced 51.57%	61,600 $2.51 Million
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $2.6 Million - $3.2 Million	74,500 Added 141.37%	127,200 $5.47 Million
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $816,167 - $1.01 Million	24,800 Added 88.89%	52,700 $2.02 Million
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $50,768 - $62,464	-1,600 Reduced 5.42%	27,900 $986,000
Q3 2018 Nov 14, 2018	SELL	$32.83 - $38.63 $15 Million - $17.6 Million	-456,200 Reduced 93.93%	29,500 $1.14 Million
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $2.35 Million - $3 Million	87,400 Added 21.94%	485,700 $15.9 Million
Q1 2018 May 15, 2018	BUY	$25.2 - $28.54 $9.74 Million - $11 Million	386,600 Added 3304.27%	398,300 $10.9 Million
Q4 2017 Feb 14, 2018	SELL	$24.79 - $29.8 $245,421 - $295,020	-9,900 Reduced 45.83%	11,700 $290,000
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $567,216 - $630,072	21,600	21,600 $630,000

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

Vanguard Group Inc Valley Forge, PA

131M
Shares

$11.9 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

126M
Shares

$11.4 Billion
0.22% of portfolio
State Street Corp Boston, MA

62.8M
Shares

$5.69 Billion
0.22% of portfolio
Primecap Management CO Pasadena, CA

37.8M
Shares

$3.43 Billion
2.37% of portfolio
Wellington Management Group LLP Boston, MA

32.8M
Shares

$2.97 Billion
0.49% of portfolio

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account